甲状腺癌相关基因的研究进展

被引：7

作者：

胡淑阳

吴艺捷

机构：

[1] 上海交通大学附属第一人民医院内分泌科

来源：

医学综述 | 2009年 / 15卷 / 13期

关键词：

甲状腺癌; 癌基因; 抑癌基因;

D O I：

暂无

中图分类号：

R736.1 [甲状腺肿瘤];

学科分类号：

100214 ;

摘要：

甲状腺癌是常见的内分泌腺恶性肿瘤。由于其起病隐匿,生物学特性多变,恶性程度高低不一,极易误诊,早期诊断是临床中的难点。目前已发现了许多甲状腺癌相关分子标志物,包括甲状腺癌相关癌基因如BRAF、Ret、Ras、Trk基因和可能具有抑制甲状腺癌生长的基因如p53、PTEN等。对这些基因的研究可能有助于建立可靠、可行的甲状腺癌早期诊断的检测手段。

引用

页码：1953 / 1956

页数：4

共 14 条

[1]

Incidentally simultaneous occurrence of RET/PTC , H4–PTEN and BRAF mutation in papillary thyroid carcinoma[J] . Yu-Long Wang,Jiu-Cun Wang,Yi Wu,Ling Zhang,Cai-Ping Huang,Qiang Shen,Yong-Xue Zhu,Duan-Shu Li,Qing-Hai Ji.Cancer Letters . 2008 (1)

[2]

Prognostic Significance of Somatic RET Oncogene Mutations in Sporadic Medullary Thyroid Cancer: A 10-Year Follow-Up Study[J] . Rossella Elisei,Barbara Cosci,Cristina Romei,Valeria Bottici,Giulia Renzini,Eleonora Molinaro,Laura Agate,Agnese Vivaldi,Pinuccia Faviana,Fulvio Basolo,Paolo Miccoli,Piero Berti,Furio Pacini,Aldo Pinchera.The Journal of Clinical Endocrinology ＆ Metabolism . 2008 (3)

[3] Phosphatidylinositol 3-Kinase/Akt and Ras/RafMitogen-Activated protein kinase pathway mutations in anaplastic thyroid cancer [J].

Santarpia, Libero ;

El-Naggar, Adel K. ;

Cote, Gilbert J. ;

Myers, Jeffrey N. ;

Sherman, Steven I. .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2008, 93 (01) :278-284

[4]

Increased Incidence of Well-Differentiated Thyroid Cancer Associated with Hashimoto Thyroiditis and the Role of the PI3k/Akt Pathway[J] . Shawn D. Larson,Lindsey N. Jackson,Taylor S. Riall,Tatsuo Uchida,Robert P. Thomas,Suimin Qiu,B. Mark Evers.Journal of the American College of Surgeons . 2007 (5)

[5]

RET oncogene amplification in thyroid cancer: correlations with radiation-associated and high-grade malignancy[J] . Masahiro Nakashima,Noboru Takamura,Hiroyuki Namba,Vladimir Saenko,Serik Meirmanov,Naomichi Matsumoto,Tomayoshi Hayashi,Shigeto Maeda,Ichiro Sekine.Human Pathology . 2007 (4)

[6] High prevalence and mutual exclusivity of genetic alterations in the phosphatidylinositol-3-kinase/Akt pathway in thyroid tumors [J].

Wang, Yangang ;

Hou, Peng ;

Yu, Hongyu ;

Wang, Wei ;

Ji, Meiju ;

Zhao, Shihua ;

Yan, Shengli ;

Sun, Xianlu ;

Liu, Dingxie ;

Shi, Bingyin ;

Zhu, Guangwu ;

Condouris, Stephen ;

Xing, Mingzhao .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2007, 92 (06) :2387-2390

[7]

BRAF V600E Maintains Proliferation, Transformation, and Tumorigenicity of BRAF-Mutant Papillary Thyroid Cancer Cells[J] . Dingxie Liu,Zhi Liu,Stephen Condouris,Mingzhao Xing.The Journal of Clinical Endocrinology ＆ Metabolism . 2007 (6)

[8] Lymphatic mapping establishes the role of BRAF gene mutation in papillary thyroid carcinoma [J].